Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery☆
نویسندگان
چکیده
•Dermatomyositis in ovarian cancer responds to treatment with neo-adjuvant carboplatin and paclitaxel in conjunction with corticosteroids.•Recurrence of dermatomyositis symptoms is often the first sign of relapsed disease.•Prognosis of ovarian cancer in context of dermatomyositis is poor.
منابع مشابه
Hyperthermic intraperitoneal chemotherapy with oxaliplatin and without adjuvant chemotherapy in stage IIIC ovarian cancer.
OBJECTIVE To assess the feasibility and efficacy of cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) without adjuvant chemotherapy for relapsed or persistent advanced ovarian cancer. METHODS This observational study included stage IIIC ovarian cancer patients due to undergo CRS (interval debulking or recurrent surgery) followed by HIPEC with oxaliplati...
متن کاملRetrospective Study Comparing Primary Debulking Surgery (PDS) with Adjuvant Chemotherapy vs. Neoadjuvant Chemotherapy (NACT) Followed by Interval Debulking Surgery (IDS) with Adjuvant Chemotherapy in Advanced Carcinoma Ovary
Introduction: Ovarian carcinoma is the major cause of mortality among women with gynecological problems as its reported very late. We have evaluated and compared two modalities of treatment for advanced (stage III and selected stage IV) ovarian cancer, done at our hospital from January 2003 to June 2010 and also analyzed patient, tumour, and treatment related variables. Materials and Methods: R...
متن کاملRobotic-assisted minimally invasive surgery and ovarian cancer
Ovarian cancer is the fifth most common cancer in women, and the most lethal gynecologic malignancy in western countries. Approximately 70% of malignant ovarian cancers are diagnosed with diffuse intraperitoneal spread. The treatment algorithm for ovarian cancer consists of the combination of maximal cytoreductive surgery and chemotherapy [1]. Advanced stages, requiring major tumor debulk ing, ...
متن کاملRadiation for persistent or recurrent epithelial ovarian cancer: a need for reassessment
PURPOSE The role of radiotherapy (RT) was largely deserted after the introduction of platinum-based chemotherapy, but still survival rates are disappointingly low. This study focuses on assessing the clinical efficacy of RT in relation to chemotherapy resistance. MATERIALS AND METHODS From October 2002 to January 2015, 44 patients were diagnosed with epithelial ovarian cancer (EOC) and treate...
متن کاملNeoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
BACKGROUND Primary debulking surgery before initiation of chemotherapy has been the standard of care for patients with advanced ovarian cancer. METHODS We randomly assigned patients with stage IIIC or IV epithelial ovarian carcinoma, fallopian-tube carcinoma, or primary peritoneal carcinoma to primary debulking surgery followed by platinum-based chemotherapy or to neoadjuvant platinum-based c...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 6 شماره
صفحات -
تاریخ انتشار 2013